Gemcitabin Kabi 38 mg/ml Pulver zur Herstellung einer Infusionslösung clinical trials

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus–Pancreatic Cancer)

This study is testing different combinations of new drug treatments for people with advanced pancreatic cancer. Doctors want to see how well these combinations shrink tumours and if they are safe to use.